Floatz logo

Ifosfamide

Oral Complications

Jonsson Comprehensive Cancer CenterPhase 2Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Oral Complications cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Jonsson Comprehensive Cancer Center
Phase 3BB
Carboplatin
Radiation Therapy Oncology Group
Phase 3BB
CALCIUM PHOSPHATE
Impaqtt Foundation
Phase 3BB
Amifostine
Radiation Therapy Oncology Group
Phase 3B
ETOPOSIDE
Jonsson Comprehensive Cancer Center
Phase 2B

View all 12 →

Same molecule, other indications

Ifosfamide is also rated in:

angioimmunoblastic T-cell lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
primary mediastinal large B-cell lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →